May 16, 2022
Saddled with a net loss exceeding 100 billion yen, Nichi-Iko Pharmaceutical has filed for an out-of-court process to reorganize its debts, bidding to turn around its business battered by US pipeline delays and supply disruptions that followed its GMP violations...read more